Recipient's Killer Cell Immunoglobulin-like Receptor Genotype and Human Leukocyte Antigen C Ligand Influence the Clinical Outcome following Living Donor Liver Transplantation
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.